Denise Whitby

15.8k total citations · 3 hit papers
217 papers, 10.8k citations indexed

About

Denise Whitby is a scholar working on Oncology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Denise Whitby has authored 217 papers receiving a total of 10.8k indexed citations (citations by other indexed papers that have themselves been cited), including 188 papers in Oncology, 105 papers in Epidemiology and 85 papers in Infectious Diseases. Recurrent topics in Denise Whitby's work include Viral-associated cancers and disorders (186 papers), Cytomegalovirus and herpesvirus research (88 papers) and Parvovirus B19 Infection Studies (73 papers). Denise Whitby is often cited by papers focused on Viral-associated cancers and disorders (186 papers), Cytomegalovirus and herpesvirus research (88 papers) and Parvovirus B19 Infection Studies (73 papers). Denise Whitby collaborates with scholars based in United States, United Kingdom and Uganda. Denise Whitby's co-authors include Vickie Marshall, Thomas F. Schulz, Robin A. Weiss, Thomas S. Uldrick, Robert J. Biggar, Robert Yarchoan, James J. Goedert, Wendell Miley, Eric A. Engels and Chris Boshoff and has published in prestigious journals such as Nature, New England Journal of Medicine and The Lancet.

In The Last Decade

Denise Whitby

213 papers receiving 10.6k citations

Hit Papers

Detection of Kaposi sarcoma associated herpesvirus in per... 1995 2026 2005 2015 1995 1995 2019 200 400 600

Peers

Denise Whitby
George Miller United States
Daniel M. Knowles United States
Richard F. Ambinder United States
Dirk P. Dittmer United States
Blossom Damania United States
Ethel Cesarman United States
Rajiv Khanna Australia
Denise Whitby
Citations per year, relative to Denise Whitby Denise Whitby (= 1×) peers Thomas F. Schulz

Countries citing papers authored by Denise Whitby

Since Specialization
Citations

This map shows the geographic impact of Denise Whitby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Denise Whitby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Denise Whitby more than expected).

Fields of papers citing papers by Denise Whitby

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Denise Whitby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Denise Whitby. The network helps show where Denise Whitby may publish in the future.

Co-authorship network of co-authors of Denise Whitby

This figure shows the co-authorship network connecting the top 25 collaborators of Denise Whitby. A scholar is included among the top collaborators of Denise Whitby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Denise Whitby. Denise Whitby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ramaswami, Ramya, Kathryn Lurain, Mark N. Polizzotto, et al.. (2025). Characteristics and outcomes of Kaposi sarcoma herpesvirus–associated inflammatory cytokine syndrome. Blood Advances. 9(22). 5720–5731. 1 indexed citations
2.
Lurain, Kathryn, Ramya Ramaswami, Laurie T. Krug, et al.. (2024). HIV-associated cancers and lymphoproliferative disorders caused by Kaposi sarcoma herpesvirus and Epstein-Barr virus. Clinical Microbiology Reviews. 37(3). e0002223–e0002223. 11 indexed citations
4.
Caduff, Nicole, Donal McHugh, Wendell Miley, et al.. (2024). KSHV infection of B cells primes protective T cell responses in humanized mice. Nature Communications. 15(1). 4841–4841. 3 indexed citations
5.
Sabourin, Katherine R., Joseph Mugisha, Gershim Asiki, et al.. (2023). Epstein–Barr virus (EBV) antibody changes over time in a general population cohort in rural Uganda, 1992–2008. Infectious Agents and Cancer. 18(1). 55–55. 3 indexed citations
7.
Nalwoga, Angela, Katherine R. Sabourin, Wendell Miley, et al.. (2023). Plasmodium falciparum Malaria Is Associated With Increased Kaposi Sarcoma–Associated Herpesvirus (KSHV) Seropositivity and Higher KSHV Antibody Breadth and Magnitude: Results of a Case-Control Study From Rural Uganda. The Journal of Infectious Diseases. 229(2). 432–442. 1 indexed citations
8.
Lazarte, Susana, Radhika Kainthla, Wendell Miley, et al.. (2023). High Seroprevalence of Kaposi Sarcoma–Associated Herpesvirus in Men Who Have Sex With Men With HIV in the Southern United States. Open Forum Infectious Diseases. 10(4). ofad160–ofad160. 6 indexed citations
9.
Casper, Corey, Lawrence Corey, Jeffrey I. Cohen, et al.. (2022). KSHV (HHV8) vaccine: promises and potential pitfalls for a new anti-cancer vaccine. npj Vaccines. 7(1). 108–108. 35 indexed citations
10.
Marshall, Vickie, Charles Goodman, Abigail L. Thorpe, et al.. (2022). Systematic analysis of Kaposi's sarcoma (KS)‐associated herpesvirus genomes from a KS case‐control study in Cameroon: Evidence of dual infections but no association between viral sequence variation and KS risk. International Journal of Cancer. 151(7). 1127–1141. 7 indexed citations
11.
Nalwoga, Angela, Vickie Marshall, Wendell Miley, et al.. (2021). Kaposi’s sarcoma-associated herpesvirus T cell responses in HIV seronegative individuals from rural Uganda. Nature Communications. 12(1). 7323–7323. 21 indexed citations
12.
Sallah, Neneh, Wendell Miley, Nazzarena Labò, et al.. (2020). Distinct genetic architectures and environmental factors associate with host response to the γ2-herpesvirus infections. Nature Communications. 11(1). 3849–3849. 23 indexed citations
13.
Ramaswami, Ramya, Thomas S. Uldrick, Mark N. Polizzotto, et al.. (2019). A Pilot Study of Liposomal Doxorubicin Combined with Bevacizumab followed by Bevacizumab Monotherapy in Patients with Advanced Kaposi Sarcoma. Clinical Cancer Research. 25(14). 4238–4247. 23 indexed citations
14.
Labò, Nazzarena, Vickie Marshall, Wendell Miley, et al.. (2019). Mutual detection of Kaposi's sarcoma‐associated herpesvirus and Epstein–Barr virus in blood and saliva of Cameroonians with and without Kaposi's sarcoma. International Journal of Cancer. 145(9). 2468–2477. 33 indexed citations
15.
Lurain, Kathryn, Mark N. Polizzotto, Karen Aleman, et al.. (2019). Viral, immunologic, and clinical features of primary effusion lymphoma. Blood. 133(16). 1753–1761. 83 indexed citations
16.
Liu, Zhiwei, Kelly J. Yu, Anna E. Coghill, et al.. (2019). Multilaboratory Assessment of Epstein-Barr Virus Serologic Assays: the Case for Standardization. Journal of Clinical Microbiology. 57(11). 7 indexed citations
17.
Hwang, Amie E., Vickie Marshall, David V. Conti, et al.. (2018). Epstein–Barr virus load is higher in long‐term Hodgkin lymphoma survivors compared to their unaffected twins and unrelated controls. British Journal of Haematology. 185(2). 377–380. 2 indexed citations
18.
Polizzotto, Mark N., Thomas S. Uldrick, Kathleen M. Wyvill, et al.. (2016). Pomalidomide for Symptomatic Kaposi's Sarcoma in People With and Without HIV Infection: A Phase I/II Study. Journal of Clinical Oncology. 34(34). 4125–4131. 86 indexed citations
19.
Whitby, Denise, Yolanda Benavente, Wendell Miley, et al.. (2015). Hepatitis C virus seroprevalence in the general female population from 8 countries. Journal of Clinical Virology. 68. 89–93. 9 indexed citations
20.
Uldrick, Thomas S., Mark N. Polizzotto, Karen Aleman, et al.. (2014). Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease. Blood. 124(24). 3544–3552. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026